5 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global

Page 5 of 5

1. Roivant Sciences Ltd. (NASDAQ:ROIV)

Viking Global’s Stake Value: $889 million

Percentage of Viking Global’s 13F Portfolio: 2.57%

Number of Hedge Fund Holders: 23

Share Price on April 26, 2022: $3.8

Roivant Sciences Ltd. (NASDAQ:ROIV) is a British biotechnology company based in London. The firm develops treatments for cancers, tumors, dermatitis, sickle cell diseases, thyroid eye problems, and more.

Roivant Sciences Ltd. (NASDAQ:ROIV) managed to bring in $24.34 million in revenue and -$0.41 in GAAP EPS for its fourth fiscal quarter. Goldman Sachs set a $15 price target for the company in December 2021, as it explained that the company’s subsidiaries have a promising future.

Mr. Halvorsen’s Viking Global owned a massive $889 million stake in Roivant Sciences Ltd. (NASDAQ:ROIV) as part of its Q4 2021 investments. The stake came through the firm owning 88 million shares. For the same time period, 23 of the 924 hedge funds part of Insider Monkey’s survey had invested in the company.

Disclosure: None. You can also take a look at 10 Best Semiconductor Stocks to Invest in According to Ken Griffin’s Citadel Investment Group and 12 Best Large-cap Biotech Stocks To Buy Now.

Page 5 of 5